Drug Legalization, Harm Reduction, and Drug Policy
- Eric A. Voth, MD; and
- Robert L. DuPont, MD
- International Drug Strategy Institute; Topeka, KS 66606 Institute for Behavior and Health Rockville, MD 20852
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
IN RESPONSE:
As we pointed out in our article on drug policy [1], the …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
